Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term follow-up of knee replacement after strontium ranelate vs placebo in knee osteoarthritis
2011-004046-18Phase 3Completed
- Sponsor
- Servier
- Start
- Jan 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of strontium ranelate in knee osteoarthritis (OA) (2 arms), sponsored by Servier. Primary endpoint: Knee joint replacement in the target knee. Started Jan 2012; status: completed.
02
Drugs
strontium ranelate
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on 2011-004046-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-004046-18.